Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Cefuroxime & Potassium Clavulanate Tablets bulk supplier for pharma manufacturers

Cefuroxime & Potassium Clavulanate Tablets 625 mg, 312.5 mg , 156.25 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 625 mg, 312.5 mg , 156.25 mg

Reference Brands: -

Category: Antibiotics

Cefuroxime axetil with potassium clavulanate tablets in 625 mg, 312.5 mg and 156.25 mg totals, an oral cephalosporin combination for importers and distributors in markets where it is registered.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Cefuroxime & Potassium Clavulanate Tablets? List it or send an offer →

Product Description:

This tablet combines cefuroxime axetil, an oral second-generation cephalosporin, with potassium clavulanate, a beta-lactamase inhibitor. Cefuroxime binds penicillin-binding proteins and stops bacteria building cell walls; the axetil ester is absorbed and released as active cefuroxime. Clavulanic acid shields it from some beta-lactamases. The figures 625 mg, 312.5 mg and 156.25 mg are totals: 500, 250 or 125 mg cefuroxime with 125, 62.5 or 31.25 mg clavulanic acid. Major reference regulators approve cefuroxime axetil alone, not this pairing.

Where registered, it is prescribed for respiratory tract infections, sinusitis, otitis media, skin infections and uncomplicated urinary infections caused by susceptible organisms. Cefuroxime already resists many beta-lactamases, so the value of added clavulanate is debated. Tablets are taken twice daily after food, which improves absorption, and swallowed whole because crushed cefuroxime axetil tastes very bitter. Beta-lactam allergy must be checked. Diarrhoea is common and Clostridioides difficile infection can occur. Clavulanate is linked to cholestatic liver injury.

Sourcing notes. Confirm the combination and the strength you need are registered in your market. Clavulanate is very hygroscopic, so manufacture under low humidity and alu-alu blisters or desiccated packs are standard; ask for zone IVb stability data if you supply hot humid markets. Beta-lactams require segregated manufacturing, so ask how cross-contamination is controlled. Request a CTD or ACTD dossier, a CoA per batch with assay of both actives, water content and dissolution, the GMP certificate and a CoPP. It is prescription-only. Name the strength, pack size and label language in your enquiry.

Cefuroxime & Potassium Clavulanate Tablets — third party manufacturing & bulk supply

Cefuroxime & Potassium Clavulanate Tablets 625 mg, 312.5 mg , 156.25 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Cefuroxime & Potassium Clavulanate Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cefuroxime & Potassium Clavulanate Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Cefuroxime & Potassium Clavulanate Table... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Cefuroxime & Potassium Clavulanate Tablets is listed as Tablets in 625 mg, 312.5 mg , 156.25 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cefuroxime & Potassium Clavulanate Tablets is referenced against -. Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Cefpodoxime Proxetil Tablets

Strength:
50 mg, 100 mg, 200 mg

Form: Tablets

Reference Brands: Vantin (US), Orelox (EU)

View Details
Cefpodoxime & Potassium Clavulanate Tablets

Strength:
325mg

Form: Tablets

Reference Brands: -

View Details
Cephalexin Tablets

Strength:
125 mg, 250 mg, 500 mg

Form: Tablets

Reference Brands: Keflex (USA)

View Details
Ciprofloxacin / Tinidazole Tablets

Strength:
500mg + 600mg

Form: Tablets

Reference Brands: -

View Details
Clindamycin Injection (IV/IM)

Strength:
300 mg/2 mL, 600 mg/4 mL

Form: Injection (IV/IM)

Reference Brands: Cleocin, Dalacin C(US); Dalacin C (EU)

View Details
Clindamycin Suspension

Strength:
75 mg/5 mL, 150 mg/5 mL, 300 mg/5 mL

Form: Suspension

Reference Brands: Cleocin(USA), Dalacin C(LATAM)

View Details
Lincomycin Oral Capsules/Tablets

Strength:
250mg, 500 mg

Form: Oral Capsules/Tablets

Reference Brands: Lincocin (US)

View Details
Lincomycin Injectable (IV/IM)

Strength:
600 mg/2 mL, 1 g/2 mL, 2 g/2 mL

Form: Injectable (IV/IM)

Reference Brands: Lincocin (US & EU)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us